Randomised Trial Comparing Prednimustine With Combination Chemotherapy In Advanced Ovarian Carcinoma
Below is result for Randomised Trial Comparing Prednimustine With Combination Chemotherapy In Advanced Ovarian Carcinoma in PDF format. You can download or read online all document for free, but please respect copyrighted ebooks. This site does not host PDF files, all document are the property of their respective owners.
COMBINATION THERAPY FOR THE TREATMENT OF
15 May 2019 Randomized intergroup trial of cisplatin-paclitaxel versus compared to a platinum-resistant ovarian cancer patient receiving said
Myelotoxicity as a Prognostic Factor in Patients with Advanced
by AK KOUTRAS 2008 Cited by 16 advanced breast cancer enrolled in two randomised trials, who received first-line chemotherapy. The impact of severe. (grade 3 or 4) hematological toxicity
SEzary syndrome - USCLC
by EA Olsen 2010 Cited by 189 (Table I) or as part of combination therapy specifi- cally in SS (Table II), although randomized trials comparing ECP with other.
ProQuest Dissertations - UA Campus Repository - University
therapy is also employed, usually in combination with surgery to treat localized disease (Fisher treatment of lymphoma, breast cancer and ovarian cancer.
Clinical and Prognostic Tools to Improve - UQ eSpace
by J Tobin 2021 cohort study to describe modern-era survival outcomes, compare management approaches *Risk-Adapted Therapy in Follicular Lymphoma: Is it time to FLEX?
13 May 2019 Staging of Gastric MALT Lymphoma: Comparison of Different Systems Footnote was removed, Clinical trials of adjuvant therapy or for.
Dose intensity analysis in advanced ovarian - Europe PMC
by V Torril 1993 Cited by 17 chemotherapy for advanced ovarian cancer patients pub- Randomized trial comparing prednimustine with combination chemotherapy in advanced ovarian
Pharmaceuticals a review of human carcinogens (IARC
2.1 Cancers following treatment for various diseases. In a randomized therapy trial of 431 patients with polycythaemia vera (Berk et al., 1981), a.
A phase I/II clinical trial of fludarabine, bendamustine, and
by A Jalayer 2014 maximum tolerated dose of bendamustine combined with fixed- dose fludarabine and rituximab (FBR) in previously treated patients with CLL.
Deca-Durabolin s=r and cytotoxic drugs - Bioscientifica
anabolic action. In the next study 2 groups of patients with advanced breast cancer were treated with combination therapy consisting of thiotepa.
Cytotoxic Drugs and Hormonal Manipulations in the
by ASD Spiers Cited by 3 complete surgical resection of bladder cancers is being studied in randomized controlled trials. The need for effective adjuvant chemo- therapy is undoubted
TARGETING THE BCL-2 MEDIATED ANTI - UNSWorks
by LM High 2012 In vivo efficacy of VCR/DEX/L-ASP combination therapy against two MLL CEP-701 has been tested in a randomised trial of salvage chemotherapy followed by.
systematic meta-analyses of individual patient data - Nature
chemotherapy in advanced ovarian cancer using updated indi- (1989) Randomised trial comparing prednimustine with combination chemotherapy in advanced
This work is protected by copyright and other intellectual
by E Robinson 2015 Cited by 2 Platinum-based therapy in combination with other ovarian cancer improved PFS compared to chemotherapy alone (GOG 218: 14.1.
Chemotherapy in advanced ovarian cancer - The BMJ
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma. Cancer ChemotherPharmacol 1989;23:105-10. 33 Masding J,
A prognostic model for ovarian cancer - Imperial Spiral
by TG Clark Cited by 235 and indices in ovarian cancer should be developed using large databases and, ideally, survival, with c = 0.5 for random predictions and c = 1 for a.
10. Ovarian Cancer - SBU
and its demonstrated effect in advanced ovarian cancer, radiotherapy In one study adjuvant chemotherapy with cisplatin in early stages of.
Australian Public Assessment Report for Rituximab - TGA
19 Feb 2010 The recommended dosage in combination with chemotherapy is A randomised phase II study of rituximab plus cladribine, with or without
Randomised trial comparing prednimustine with combination
by RCF Leonard 1989 Cited by 14 Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma. Robert C. F. Leonard 1, George E. Smart 2,
CPY Document - IARC Publications
Rarely, results from randomized trials may be available. Case Alternatively, the condition for which the drug therapy is prescribed may itself be a.
Untitled - Milton S. Hershey Medical Center Penn State Health
cancer. Data from the Women's Health initiative randomized trial of estrogen plus It should be noted that some patients with advanced ovarian cancer.
AIOM Papers Selected for Plenary Session - SAGE Journals
combination chemotherapy regimen or no treatment Baseline eligibility criteria prospective, randomised multicenter study (LA02 protocolj comparing.
Topotecan, pegylated liposomal doxorubicin - NICE
topotecan versus paclitaxel in advance epithelial ovarian carcinoma. effectiveness, randomised controlled trials (RCTs) that compared topotecan.
to chlorambucil plus prednisolone in advanced breast cancer
by J Løber 1983 Cited by 34 A Phase Ill Trial Comparing Prednimustine (LEO 7037) to combination chemotherapy and endocrine therapy, and.
Review of Interferon Biology, Clinical Applications, and
melanoma, renal cell carcinoma, AIDS-related Kaposi's sarcoma, follicular lymphoma, hairy cell IFN therapy is associated with significant side effects.
Efficacy, pharmacokinetics, and safety of the biosimilar CT
by M Ogura 2018 Cited by 32 which have revolutionised cancer therapy, are associated multinational, phase 3, randomised controlled trial suggest a role.
Cisplatinum and prednimustine, an active regimen for
by JF Smyth 1991 80 patients with advanced epithelial ovarian carcinoma were treated for 6 months with cisplatinum We have recently reported a randomised comparison.
Analytics for Improved Cancer Screening and Treatment John
by J Silberholz 2015 Cited by 1 performs a large, randomized comparison of a therapy against a standard combining the results of all published randomized trials that
British HIV Association guidelines for HIVassociated
by B Gazzard Cited by 111 11.6 Combination antiretroviral therapy (cART). 11.7 Rituximab. 11.8 Chemotherapy A randomized trial compared two regimens: 24 Gy in.
Chemotherapy In Advanced Ovarian Cancer: An - JSTOR
1991 Cited by 80 randomised trial in advanced disease found that Hexa. CAF, a combination of cy to trials of chemo? therapy in advanced ovarian carcinoma that met the.
Book 8 - Antineoplastic Drugs - Surveillance, Epidemiology
This new approach to cancer therapy made it possible to treat disease which had Phase III clinical trials compare the efficacy of astandard drug (or
NCCN Clinical Practice Guidelines in Oncology (NCCN
follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood.
Impact of constitutional polymorphisms in immune effector
25 Oct 1974 The idea of combining radiation therapy with rituximab is trials comparing this approach with immediate chemotherapy with, respectively,.
Primær behandling av ovarialcancer - FHI
Chemotherapy for advanced ovarian cancer, 2000 (4) Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
MONDAY AUGUST 25 MORNING 481 A-13 - Karger
in order to decide postoperative therapy. In 75 cases of At the Osaka Cancer Registry a comparative study was conducted on lung cancer in co-operation
A Systematic Overview of Chemotherapy Effects in Ovarian
by T Högberg 2001 Cited by 142 In two prospective randomised trials in advanced ovarian cancer, paclitaxel in combination with cisplatin has provided a survival.
advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo- Fountzilas, Phase I trial of weekly irinotecan and paclitaxel combined with.
Survival Benefits With Diverse Chemotherapy Regimens for
by M Kyrgiou 2006 Cited by 201 Background: Numerous randomized trials have compared different chemotherapy regimens in women with ovarian can- cer. Although ovarian cancer
Other Chemotherapeutic Agents in Cutaneous T-Cell
by CG Chung 2015 Cited by 2 Combination chemotherapy used in the treatment of mycosis fungoides/Sйzary syndrome. Therapy Regimen. No. of. Patients. Complete. Response D.
(NCCN Guidelines®) B-Cell Lymphomas
26 Feb 2018 Staging of Gastric MALT Lymphoma: Comparison of Different Systems Footnote was removed, Clinical trials of adjuvant therapy or for.
ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF
22 Feb 2011 of anti-VEGF maintenance therapy) compared to a control. Figure 1 depicts the study design for the ovarian cancer trial described in
Investigating the role of tumour-associated - QMRO Home
by SL Hallam 2012 4.3.6 Counting tumour-associated macrophages in relation to therapy in FL. chemotherapy for ovarian cancer with cisplatin and cyclophosphamide showing.
UNSCEAR 2000 Report - Annex H
estimate cancer risk by comparing their mutagenicity relative to that of x rays. in optimizing combination therapy [L16, R4], but are of less.
Follicular and Diffuse Large B-Cell Lymphoma - Studies of
13 Apr 2018 Randomized phase III trials on the treatment of DLBCL published since immediate intensive combined modality therapy with a multidrug
Art. 30 Etopophos - Assessment Report - European Medicines
21 Apr 2017 These include one randomised clinical trial (RCT), and provide evidence as combination therapy, more recent procedures of etoposide
Chemotherapy Strategies to Improve the Control of Hodgkin's
by G Bonadonna 1982 Cited by 113 randomized study (2), the 5-year RFS following MOPP chemo therapy was 50%. Our comparative analysis of total survival,. 4314. CANCER RESEARCH VOL. 42.
Rituximab for the first-line treatment of stage III IV follicular
line therapy of rituximab in combination with chemotherapy, Conclusions: The results from four randomised trials comparing R-chemotherapy with.
Preoperative intraarterial chemotherapy in locally advanced soft tissue sarcomas may a randomized phase II trial comparing CTX with.
Elisabeth S Thesis web utan manus - LU Research Portal
by E Szekely 2018 Randomized phase III trials on the treatment of DLBCL published since immediate intensive combined modality therapy with a multidrug
Posters - ICML
SURVIVAL FOLLOWING COMBINATION CHEMOTHERAPY IN ADVANCED HIGH- ogy, stage and initial treatment were compared in short-term and long-term survivors.